Nymox Pharmaceutical Corporation (NYMX) : The short interest in Nymox Pharmaceutical Corporation (NYMX) has increased from 1,812,814 to 2,061,639 from Jul 29, 2016, to August 15, 2016, indicating that the traders are bearish on the stock. On an average, 1,237,959 shares are traded daily in the stock and only 2 days are left for the shorts to cover. The short open interest is 4.9% of the total shares in the hands of the public. The shorts in the stock have gone up by 248,825 shares, which is an increase of 13.7% over the previous reading. The short interest information was released on Wednesday Aug 24th after the market close.
Nymox Pharmaceutical Corporation (NASDAQ:NYMX): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $2.43 and $2.43 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $4.58. The buying momentum continued till the end and the stock did not give up its gains. It closed at $4.45, notching a gain of 83.13% for the day. The total traded volume was 11,984,576 . The stock had closed at $2.43 on the previous day.
In a related news, The Securities and Exchange Commission has divulged in a Form 4 filing that the director of Nymox Pharmaceutical Corp, Robinson James George had purchased shares worth of $1,235 in a transaction dated on August 10, 2016. A total of 500 shares were purchased at a price of $2.47 per share. The information is based on open market trades at the market prices.Option exercises are not covered.